The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.Yunnan Germanium Industry: downstream customers didn't feedback that the company germanium was directly used in quantum chip products. Some investors asked Yunnan Germanium Industry (002428) on the interactive platform: in quantum computing and quantum communication, germanium is widely used in the manufacturing process of quantum chips, which can achieve excellent performance. Excuse me, does the company have germanium products used in quantum chips? Yunnan Germanium Industry replied that at present, the downstream customers of the company have not reported to the company that it is directly used in this product.Runhe Software and other 300 million yuan set up a venture capital fund partnership. The enterprise search APP shows that Yuanshi (Changzhou) venture capital fund partnership (limited partnership) was established recently with a capital contribution of 300 million yuan, and its business scope includes: venture capital (limited investment in unlisted enterprises); Engage in equity investment, investment management, asset management and other activities with private equity funds. Enterprise equity penetration shows that the enterprise is jointly held by Runhe Software.
Meitu, a Hong Kong stock company, rose more than 10% in intraday trading, with turnover exceeding HK$ 400 million.Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.The yield spread of US 10-year Treasury bonds relative to China's has widened to about 250 basis points, the largest in 22 years.
The Ministry of Water Resources started the emergency water quantity dispatching of the Pearl River during the dry season from 2024 to 2025. It was learned from the Ministry of Water Resources that the first emergency water quantity dispatching of the Pearl River during the dry season from 2024 to 2025 was started at 8: 00 on December 12. According to the Ministry of Water Resources, through the implementation of this emergency water regulation, the runoff of the lower reaches of Xijiang River and Beijiang River will continue to increase, which can effectively suppress the salty tide in the Pearl River estuary and increase the water storage capacity of local reservoirs in Zhuhai and other places. The Ministry of Water Resources will guide the Pearl River Water Conservancy Commission and the water conservancy departments of the relevant provinces (autonomous regions) to closely monitor the rain, water and salt conditions in the Pearl River Basin, forecast the scope and extent of the upstream influence of salt tide, issue early warning in time, implement unified dispatching of river basin water projects, and make every effort to ensure the water supply safety of important cities in Guangdong-Hong Kong-Macao Greater Bay Area.The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.Trump said that he chose Kari Lake as the director of VOA.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide